The Society for Research on Nicotine and Tobacco and the Association for the Treatment of Tobacco Use and Dependence have developed a position statement recommending access to smoking cessation interventions for smokers in the high-risk group who undergo a lung cancer screen.
The Society for Research on Nicotine and Tobacco (SRNT) and the Association for the Treatment of Tobacco Use and Dependence (ATTUD) have developed a position statement recommending access to smoking cessation interventions for smokers in the high-risk group who undergo a lung cancer screen.
Published in Cancer, the authors conducted a literature review that supports the health benefits associated with smoking cessation in the high-risk group. According to the American Association for Thoracic Surgery, the high-risk group is defined by individuals 55 to 79-years old with a 30 pack-year history of smoking. In the current statement, SRNT and ATTUD provide clinical recommendations for integrating evidence-based smoking-cessation treatment with lung cancer screening.
In 2014, the US Preventive Services Task Force finalized a “B” recommendation for annual lung cancer screenings with low dose computed tomography (LDCT) for those identified as being at high-risk for developing lung cancer. Subsequently, in 2015, CMS announced a national coverage determination for LDCT screening as a preventive service benefit for these individuals if they received a written order from their healthcare provider.
“Lung screening with low dose CT will save many lives by detecting lung cancer at earlier, treatable stages,” said Benjamin A. Toll, PhD, associate professor of public health at the Medical University of South Carolina, in a statement. Toll is a co-author on the paper. “However, it is critical that we provide tobacco treatment in conjunction with lung screening. Most patients will not have lung cancer, and we do not want this to be perceived as a ‘free pass’ to smoke. We also wanted to highlight the multiple benefits of smoking cessation.”
Based on their review of evidence, the authors have suggested the following:
Toll believes, “Quitting smoking is the most important step patients can take to minimize risk for lung cancer and to also improve overall health. Combining smoking cessation with lung cancer screening will maximize the benefits of screening.”
Reference
Fucito LM, Czabafy S, Hendricks PS, Kotsen C, Richardson D, Toll BA. Pairing smoking-cessation services with lung cancer screening: a clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco [published online February 2, 2016]. Cancer. 2016. doi: 10.1002/cncr.29926
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
AA Unlikely to Cause Anxiety, Depression but May Be Affected by Mental Illness
May 7th 2024A Mendelian randomization study using genetic analysis found that alopecia areata (AA) increases the risk of anxiety and depression, but not the other way around, providing unique evidence for a causal link while adding to existing evidence.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
AUA Session Highlights the General Urologist’s Role in Gender-Affirming Care
May 7th 2024During her session, Polina Reyblat, MD, Kaiser Permanente Los Angeles Medical Center, highlighted best practices urologists should incorporate to make transgender and gender-diverse patients comfortable during physical exams and avoid retraumatization.
Read More